Rezultati pretraživanja
  1. 28. sij

    . published first on in 2000 covering both and . Since these conditions require different treatment strategies, the first was produced in 2004 and now updated every year based on and

    15 proslijeđenih tweetova 36 korisnika označava da im se sviđa
  2. 2. ruj 2017.

    Performing a TURBT is like making love. Enjoy the procedure!

    1 reply 21 proslijeđeni tweet 32 korisnika označavaju da im se sviđa
  3. 22. ruj 2017.

    Please do not have flu jab 6 weeks either side of BCG instillations As you will delay your cancer treatments by 6wks

    the flu season is here! We will be in the atrium Monday from 6.30am
    6 proslijeđenih tweetova 5 korisnika označava da im se sviđa
  4. 29. sij

    Ashish Kamat, MD, MBBS, discusses the approval of for high-risk non-muscle invasive ():

    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
  5. 28. sij

    via Advancements in Treating NMIBC: Pembrolizumab FDA-Approved for High-Risk Non-Muscle Invasive Bladder Cancer

    1 korisnik označava da mu se sviđa
  6. 28. sij

    Insightful talk on from Dr. . Welcome to New York :) Thanks for hosting that.

    Great Seminar Series lecture today , "Novel Therapy of High Risk Non-Muscle Invasive ," by Gary D. Steinberg, M.D., Prof. and Dir. Perlmutter Cancer Center and , with intro by EIPM's Bishoy Faltas, M.D. ()
    7 korisnika označava da im se sviđa
  7. 12. sij

    Feel so honoured to chair a poster session on with and ! My absolute pleasure beyond words... Thank you !

    10 replies 11 proslijeđenih tweetova 113 korisnika označava da im se sviđa
  8. 11. sij

    ., takes the stage at to provide a phenomenal overview of IO in , incl data from his plenary session at & recent approval & avelumab maintenance. Lots of citations from & others

    9 proslijeđenih tweetova 30 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  9. 8. sij

    Comparison of standard vs palliative management for in patients >85 years: multicentre study. Chronological age should not be a contraindication for applying standard therapies in

    18 proslijeđenih tweetova 50 korisnika označava da im se sviđa
  10. 26. pro 2019.

    : 🔶 2019’s most popular webcast in the field of BCa: “Intravesical alternatives for non-muscle-invasive bladder cancer treatment” by at 👉

    21 proslijeđeni tweet 44 korisnika označavaju da im se sviđa
  11. 15. stu 2019.

    I must say, it is my absolute honour to review the abstracts for . Thank you for the opportunity. Very high standard... Looking forward to the meeting already!!

    7 replies 13 proslijeđenih tweetova 108 korisnika označava da im se sviđa
  12. 3. stu 2019.

    For and the risk of obturator kick I feel safer to use loop and short energy “shots”

    12 replies 37 proslijeđenih tweetova 189 korisnika označava da im se sviđa
  13. 30. lis 2019.

    For you can use Collings knife if posterior aspect of is approachable

    28 proslijeđenih tweetova 101 korisnik označava da mu se sviđa
  14. 27. lis 2019.

    In recurrent small papilary , fulguration is better, not : less op time, less urethral damage, less bladder scar, less catheter time, less risk of complications This 61yo male with 14 small, 2-to-8 mm tumors, the 4th recurrence of Ta tumor in 4 years

    1 reply 7 proslijeđenih tweetova 26 korisnika označava da im se sviđa
  15. 22. ruj 2019.

    Dx. multicentric . Surgical hist. Previous . Qx. resection w/ . Thanks to for the opportunity to learn.

    5 proslijeđenih tweetova 36 korisnika označava da im se sviđa
  16. 4. ruj 2019.

    Theralase Annouces First Patient Treated in Phase II Non-Muscle Invasive Bladder Cancer Clinical Study with Intravesical Photodynamic Therapy

    1 reply 4 proslijeđena tweeta 28 korisnika označava da im se sviđa
  17. 31. kol 2019.

    shortage in low and mid income countries is even more challenging!

    How can we treat nonmuscle invasive bladder carcinoma when BCG is not available?
    9 replies 30 proslijeđenih tweetova 58 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  18. 7. lip 2019.

    resection of by means of laser by ... precise resection control avoiding damages to ureteral Origice in a completely bloodless field.

    14 replies 66 proslijeđenih tweetova 323 korisnika označavaju da im se sviđa
  19. 1. lip 2019.

    ⁦⁩ ⁦⁩ ⁦⁩ Another piece in the mosaic of information just published: En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study

    8 proslijeđenih tweetova 24 korisnika označavaju da im se sviđa
  20. 4. tra 2019.

    My great pleasure to talk about at Singapore ! Loads of work to define the future directions.

    1 reply 14 proslijeđenih tweetova 43 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.